← Leaderboards
Kathleen Marie Schmainda
University Of Tx Md Anderson Can Ctr
$14,483,193
Attributed
$17,117,198
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,117,198 · 11
By mechanism
R01$11,486,729 · 5
U01$4,871,907 · 1
R21$333,300 · 1
M01$213,181 · 2
R41$212,081 · 2
Top collaborators
- Jerrold L Boxerman7 shared
- Leland Hu7 shared
- Christopher Chad Quarles7 shared
- Steven Stufflebeam4 shared
- Scott D Rand1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Christopher Chad Quarles$12,985,497
- Emil Schueler$3,463,660
- Leland Hu$3,569,147
- Jerrold L Boxerman$648,239
- Yuan Ji$1,536,757
Others in their field
Top investigators on “Magnetic Resonance Imaging”
- Michael W Weiner · Northern California Institute Res &Educ$151,227,246
- Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
- Reisa A. Sperling · Banner Health$112,709,449
- Randall J Bateman · Washington University$108,056,165
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
Magnetic Resonance ImagingBrain NeoplasmsTumorImagePerfusionRecurrenceResponseContrast MediaMapsGliomaBasePredispositionMeasurementMonitorEvaluationValidationDoseBevacizumabDiffusionDiffusion Magnetic Resonance ImagingGlioblastomaBlood VolumeImaging ModalityAngiogenesis Inhibitors
Grant awards (51)
Establishing the clinical utility of a consensus DSC-MRI Protocol$556,160
R01 · FY2025 · CA
New treatment monitoring biomarkers for brain tumors using multiparametric MRI with machine learning$510,040
R01 · FY2025 · CA · contact PI
New treatment monitoring biomarkers for brain tumors using multiparametric MRI with machine learning$509,140
R01 · FY2024 · CA · contact PI
Establishing the clinical utility of a consensus DSC-MRI Protocol$1
R01 · FY2024 · CA
Establishing the clinical utility of a consensus DSC-MRI Protocol$617,853
R01 · FY2023 · CA
New treatment monitoring biomarkers for brain tumors using multiparametric MRI with machine learning$533,880
R01 · FY2023 · CA · contact PI
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response$516,866
U01 · FY2023 · CA · contact PI
Establishing the clinical utility of a consensus DSC-MRI Protocol$681,274
R01 · FY2022 · CA
New treatment monitoring biomarkers for brain tumors using multiparametric MRI with machine learning$526,267
R01 · FY2022 · CA · contact PI
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response$522,785
U01 · FY2022 · CA · contact PI
New treatment monitoring biomarkers for brain tumors using multiparametric MRI with machine learning$547,655
R01 · FY2021 · CA · contact PI
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response$537,154
U01 · FY2021 · CA · contact PI
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response$559,217
U01 · FY2020 · CA · contact PI
Multi-site Validation and Application of a Consensus DSC MRI Protocol$124,268
R01 · FY2020 · CA
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response$584,330
U01 · FY2019 · CA · contact PI
Multi-site Validation and Application of a Consensus DSC MRI Protocol$317,574
R01 · FY2019 · CA
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response$421,960
U01 · FY2018 · CA · contact PI
Multi-site Validation and Application of a Consensus DSC MRI Protocol$295,825
R01 · FY2018 · CA
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response$421,960
U01 · FY2017 · CA · contact PI
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response$426,449
U01 · FY2016 · CA · contact PI
MRI Contrast Agent Methods to Assess Tumor Angiogenesis$290,469
R01 · FY2016 · CA · contact PI
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response$431,673
U01 · FY2015 · CA · contact PI
MRI Contrast Agent Methods to Assess Tumor Angiogenesis$290,469
R01 · FY2015 · CA · contact PI
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response$449,513
U01 · FY2014 · CA · contact PI
MRI Contrast Agent Methods to Assess Tumor Angiogenesis$281,755
R01 · FY2014 · CA · contact PI
Toward Multi-Center MR Brain Perfusion$1
R01 · FY2014 · NS
MRI Contrast Agent Methods to Assess Tumor Angiogenesis$273,041
R01 · FY2013 · CA · contact PI
Toward Multi-Center MR Brain Perfusion$177,738
R01 · FY2013 · NS
Toward Multi-Center MR Brain Perfusion$569,251
R01 · FY2012 · NS
MRI Contrast Agent Methods to Assess Tumor Angiogenesis$316,969
R01 · FY2012 · CA · contact PI
Automating MRI Delta T1 Methods for the Routine Assessment of Brain Tumor Burden$105,081
R41 · FY2012 · NS · contact PI
Toward Multi-Center MR Brain Perfusion$526,507
R01 · FY2011 · NS
MRI Contrast Agent Methods of Assessing Tumor Angiogenesis$275,179
R01 · FY2011 · CA · contact PI
MRI Contrast Agent Methods of Assessing Tumor Angiogenesis$283,690
R01 · FY2010 · CA · contact PI
MRI Contrast Agent Methods of Assessing Tumor Angiogenesis$283,690
R01 · FY2009 · CA · contact PI
MRI Contrast Agent Methods of Assessing Tumor Angiogenesis$275,868
R01 · FY2009 · CA · contact PI
MRI Contrast Agent Methods of Assessing Tumor Angiogenesis$283,690
R01 · FY2008 · CA · contact PI
A Diffusion-Based MRI Method to Detect Glioma Invasion$151,500
R21 · FY2008 · CA · contact PI
MRI Contrast Agent Methods of Assessing Tumor Angiogenesis$283,690
R01 · FY2007 · CA · contact PI
A Diffusion-Based MRI Method to Detect Glioma Invasion$181,800
R21 · FY2007 · CA · contact PI
MRI Contrast Agent Methods of Assess Tumor Angiogenesis$275,373
R01 · FY2006 · CA · contact PI
Merit of MRI Perfusion Targets for Radiotherapy Planning$107,000
R41 · FY2006 · CA · contact PI
MRI CONTRAST AGENT METHODS TO ASSESS TUMOR ANGIOGENESIS$62,415
M01 · FY2006 · RR · contact PI
MRI Contrast Agent Methods of Assess Tumor Angiogenesis$282,000
R01 · FY2005 · CA
MRI CONTRAST AGENT METHODS TO ASSESS TUMOR ANGIOGENESIS$83,961
M01 · FY2005 · RR
MRI Contrast Agent Methods of Assess Tumor Angiogenesis$282,000
R01 · FY2004 · CA
MRI Contrast Agent Methods to Assess Tumor Angiogenesis$66,805
M01 · FY2004 · RR
MRI Contrast Agent Methods of Assess Tumor Angiogenesis$282,000
R01 · FY2003 · CA
MRI CONTRAST AGENT METHODS TO ASSESS TUMOR ANGIOGENESIS$235,463
R01 · FY2002 · CA
MRI CONTRAST AGENT METHODS TO ASSESS TUMOR ANGIOGENESIS$235,463
R01 · FY2001 · CA
MRI CONTRAST AGENT METHODS TO ASSESS TUMOR ANGIOGENESIS$262,486
R01 · FY2000 · CA